Double-Dose Dolutegravir and Lamivudine Versus Efavirenz-Based Antiretroviral Therapy for Patients Coinfected with HIV and Tuberculosis: A Multicentre Open-Label, Randomised Trial

Xiaoqin Le(Shanghai Public Health Clinical Center), Yinzhong Shen(Fudan University), Renfang Zhang(Shanghai Public Health Clinical Center), Chao Wu(Guizhou University), Jiangrong Wang(Shandong First Medical University), Yanyun Dou, Xiaoxin Xie(Shanghai Public Health Clinical Center), Zhiman Xie(The Fourth People's Hospital), Zhihao Meng, Bo Tian(Kunming Third People's Hospital), Qisi Su(The Fourth People's Hospital), Yihong Zhou(Chongqing Public Health Medical Center), Yanqiu Lu(Chongqing Public Health Medical Center), Yan Sun, Yaokai Chen(Chongqing Public Health Medical Center), Jiawei He(Chinese Academy of Sciences), Aihua Deng(West Virginia University), Lianguo Ruan(Huazhong University of Science and Technology), Yang Tang(Shanghai Public Health Clinical Center), Ke Lan, Junyang Yang(Shanghai Public Health Clinical Center), Jinchuan Shi(Hangzhou Xixi hospital), Yueming Shao(Shanghai Public Health Clinical Center), Li Liu(Hangzhou Hospital of Traditional Chinese Medicine), Ke Hong(Jinyintan Hospital), Min Liu(Lanzhou Army General Hospital), Jianjun Sun(Shanghai Public Health Clinical Center), Jun Liu(Capital Medical University), Wenzhen Tu(Shanghai Public Health Clinical Center), Min Jiao, Youming Chen(Shanghai Public Health Clinical Center), Jianhua Yu(Zhejiang Chinese Medical University), Jun Chen(Shanghai Public Health Clinical Center), Ai-Chun Huang(The Fourth People's Hospital), Xuan Yang, Wei Song(University of Alabama at Birmingham), Zhenyan Wang(Shanghai Public Health Clinical Center), Yuhong Xiong(University of Science and Technology of China), Shuibao Xu(Shanghai Public Health Clinical Center), Tangkai Qi(Shanghai Public Health Clinical Center), Lin Gu(Shanghai Public Health Clinical Center), Meiyin Zou(Nantong University)
EMJ Microbiology & Infectious Diseases
May 27, 2025
Cited by 0


Related Papers